Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlio Milanese

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Respiratory Research|August 1, 2006
Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthmaG Enrico Rovati, Michele Baroffio, Simona Citro, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 6, 2003
Medical treatment reverses cytokine pattern in allergic and nonallergic chronic rhinosinusitis in asthmatic childrenMaria Angela Tosca, Cristina Cosentino, Eugenio Pallestrini, et al.
Pulmonary Pharmacology & Therapeutics|March 18, 2017
Can the response to Omalizumab be influenced by treatment duration? A real-life studyBruno Sposato, Marco Scalese, Manuela Latorre, et al.
European Annals of Allergy and Clinical Immunology|April 6, 2004
Duration of antiinflammatory and symptomatic effects after suspension of intranasal corticosteroid in persistent allergic rhinitisGiorgio Ciprandi, Vittorio Ricca, Ferrero Paola, et al.
ERJ Open Research|July 21, 2021
COVID-19 6 months after hospital discharge: pulmonary function impairment and its heterogeneityManlio Milanese, Marco Anselmo, Sandra Buscaglia, et al.
Pulmonary Pharmacology & Therapeutics|January 1, 2019
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real lifeCarlo Lombardi, Diego Bagnasco, Cristiano Caruso, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 25, 2003
Small airway morphology and lung function in the transition from normality to chronic airway obstructionAngelo Corsico, Manlio Milanese, Simonetta Baraldo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 16, 2005
A model of allergen-driven human airway contraction: beta2 pathway dysfunction without cytokine involvementManlio Milanese, Anna Maria Riccio, Cinzia Gamalero, et al.
Biomedicines|May 25, 2024
Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with MepolizumabDiego Bagnasco, Benedetta Bondi, Marco Caminati, et al.
BMJ Open Respiratory Research|October 31, 2025
Fixed airway obstruction and bronchodilator responsiveness phenotypes in severe asthma population from SANI registryGiuseppe Guida, Francesco Blasi, Giorgio Walter Canonica, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Respiratory Research|August 1, 2006
Cysteinyl-leukotrienes in the regulation of beta2-adrenoceptor function: an in vitro model of asthmaG Enrico Rovati, Michele Baroffio, Simona Citro, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|June 6, 2003
Medical treatment reverses cytokine pattern in allergic and nonallergic chronic rhinosinusitis in asthmatic childrenMaria Angela Tosca, Cristina Cosentino, Eugenio Pallestrini, et al.
Pulmonary Pharmacology & Therapeutics|March 18, 2017
Can the response to Omalizumab be influenced by treatment duration? A real-life studyBruno Sposato, Marco Scalese, Manuela Latorre, et al.
European Annals of Allergy and Clinical Immunology|April 6, 2004
Duration of antiinflammatory and symptomatic effects after suspension of intranasal corticosteroid in persistent allergic rhinitisGiorgio Ciprandi, Vittorio Ricca, Ferrero Paola, et al.
ERJ Open Research|July 21, 2021
COVID-19 6 months after hospital discharge: pulmonary function impairment and its heterogeneityManlio Milanese, Marco Anselmo, Sandra Buscaglia, et al.
Pulmonary Pharmacology & Therapeutics|January 1, 2019
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real lifeCarlo Lombardi, Diego Bagnasco, Cristiano Caruso, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 25, 2003
Small airway morphology and lung function in the transition from normality to chronic airway obstructionAngelo Corsico, Manlio Milanese, Simonetta Baraldo, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|March 16, 2005
A model of allergen-driven human airway contraction: beta2 pathway dysfunction without cytokine involvementManlio Milanese, Anna Maria Riccio, Cinzia Gamalero, et al.
Biomedicines|May 25, 2024
Evaluation of Clinical Remission in Best-Performing Severe Asthmatic Patients Treated for Three Years with MepolizumabDiego Bagnasco, Benedetta Bondi, Marco Caminati, et al.
BMJ Open Respiratory Research|October 31, 2025
Fixed airway obstruction and bronchodilator responsiveness phenotypes in severe asthma population from SANI registryGiuseppe Guida, Francesco Blasi, Giorgio Walter Canonica, et al.
Pageof 8